| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5590802 | Multiple Sclerosis and Related Disorders | 2017 | 9 Pages |
Abstract
High dose biotin was safe and well tolerated, but of no demonstrable long-term benefit. More than one-third of patients worsened while on biotin, most likely due to their disease, but in some patients also possibly due to the inability of their injured central nervous systems to respond to the increased metabolic demands induced by biotin.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Gary Birnbaum, Jessica Stulc,